Medicinal cannabis is safe and effective—it's time to reboot research

March 15, 2018, Elsevier
Credit: CC0 Public Domain

Medicinal cannabis is safe and effective in pain relief, and researchers are calling for the treatment to be properly established in our modern medical arsenal. A new special issue of the European Journal of Internal Medicine provides a comprehensive overview of current evidence for the use of cannabis and derived products in medicine, and calls for more research to improve the evidence base for its use.

"We feel it is absolutely imperative to not only present the current state of affairs, but also propose the development of the scientific research program within the paradigm of -based medicine," said Prof. Victor Novack, guest editor of the special issue and a professor at Ben-Gurion University of the Negev in Israel. "Our ultimate aim should be to scientifically establish the actual place of derived products in the modern medical arsenal."

Cannabis has been used for centuries in , as a sleep aid and for many other purposes, yet there is little evidence on its safety and effectiveness. This is in part due to relatively recent legal restrictions on its use, which have hampered research efforts and resulted in doctors having little to no understanding of its use.

However, there has been an explosion in the number of studies published since 2012. The new special issue provides two major studies on the use of cannabis in cancer patients and the elderly, as well as a comprehensive overview of the evidence, regulations, ethics and practical use. The authors and editors call for more research to improve the evidence base.

In a study led by Prof. Novack, a team of researchers from Israel analyzed data collected during the medicinal cannabis treatment of 2,970 cancer patients between 2015 and 2017. The two main problems patients were hoping to overcome were sleep problems and pain, and cannabis has been shown to be effective in alleviating both. 95.9 percent of the patients reported an improvement in their condition.

The same team also analyzed the effectiveness of medical cannabis in elderly patients who were being treated in 2015-2017 for a variety of issues, including pain and cancer. The researchers conclude in their paper: "Our study finds that the therapeutic use of cannabis is safe and efficacious in the elderly population. Cannabis use may decrease the use of other prescription medicines, including opioids. Gathering more evidence-based data, including data from double-blind randomized-controlled trials, in this special population is imperative."

In a review in the special issue, Prof. Donald Abrams at University of California San Francisco Ward in the US covers the recent review conducted by the National Academies of Sciences, Engineering and Medicine, The Health Effects of Cannabis and Cannabinoids. The report, which considered 10,000 scientific abstracts, "concluded that there was conclusive or substantial evidence that Cannabis or cannabinoids are effective for the treatment of pain in adults; chemotherapy-induced nausea and vomiting and spasticity associated with multiple sclerosis."

Yet the report also highlighted the barriers to research in the US, which may explain the lack of strong evidence for the therapeutic use of cannabis. This dearth of research has also led to numerous ethical issues in prescribing cannabis, not least because many doctors do not understand the treatment enough to advise dosage and use. An article by researchers at the University of British Columbia, Canada and International Cannabis and Cannabinoids Institute, Prague, Czech Republic provides practical guidance for doctors, with data on cannabis pharmacology.

"This Medical Cannabis special issue covers everything you wanted to know about medical cannabis," said Prof. Novack. "We hope that it will provide physicians with a contemporary summary of different aspects related to the medical cannabis and guide the choice of an appropriate for the indications where the evidence is sufficient to initiate the treatment. We also hope the articles will facilitate the conversation on the future of medical research and its accommodation into mainstream medicine."

Explore further: Medical cannabis significantly safer for elderly with chronic pain than opioids: study

More information: Lihi Bar-Lev Schleider et al, Prospective analysis of safety and efficacy of medical cannabis in large unselected population of patients with cancer, European Journal of Internal Medicine (2018). DOI: 10.1016/j.ejim.2018.01.023

Donald I. Abrams. The therapeutic effects of Cannabis and cannabinoids: An update from the National Academies of Sciences, Engineering and Medicine report, European Journal of Internal Medicine (2018). DOI: 10.1016/j.ejim.2018.01.003

Caroline A. MacCallum et al. Practical considerations in medical cannabis administration and dosing, European Journal of Internal Medicine (2018). DOI: 10.1016/j.ejim.2018.01.004

Related Stories

Medical cannabis significantly safer for elderly with chronic pain than opioids: study

February 13, 2018
Medical cannabis therapy can significantly reduce chronic pain in patients age 65 and older without adverse effects, according to researchers at Ben-Gurion University of the Negev (BGU) and the Cannabis Clinical Research ...

Comfortably numb – why some older people turn to cannabis for pain relief

February 19, 2018
When most people think of cannabis users, they probably think mainly of the younger generations. But it's actually the 45 to 64 age group who show the highest proportion of household spending on cannabis.

Questions remain about the benefits and harms of cannabis

April 3, 2017
Despite dramatic changes in the legal landscape and usage rates of cannabis, evidence is still lacking regarding its potential health and therapeutic effects. Recently, the National Academies of Sciences, Engineering, and ...

New guideline warns pain benefits of medical cannabis overstated

February 15, 2018
A new medical guideline published today suggests Canada's family physicians should take a sober second thought before prescribing medical cannabis to most patients.

Medicinal Cannabis—harms or benefits? Who decides?

December 21, 2016
Wellington researchers are calling for doctors to be more involved in the debate around cannabis as a medicine.

Canada should continue with separate medical stream after cannabis is legalized for recreational use

July 17, 2017
After cannabis is legalized, Canada should continue with a separate medical cannabis stream to keep patients safe, argues a commentary in CMAJ (Canadian Medical Association Journal)

Recommended for you

Study compares athlete and truck driver, identical twins

July 20, 2018
When it comes to being fit, are genes or lifestyle—nature or nurture—more important? Researchers at San Francisco State University, CSU Fullerton and Cal Poly, Pomona removed the nature part of the equation by studying ...

Secondhand smoke causing thousands of still births in developing countries

July 20, 2018
The study reveals that more than 40% of all pregnant women in Pakistan are exposed to secondhand smoke—causing approximately 17,000 still births in a year.

Eating iron-fortified grain improves students' attention, memory

July 18, 2018
Adolescent students in a rural school in India who consumed an iron-biofortified version of the grain pearl millet exhibited improved attention and memory compared to those who consumed conventional pearl millet, according ...

Vaping tied to blood clots—in mice

July 18, 2018
A new study involving mice raises another concern about the danger of e-cigarettes in humans after experiments showed that short-term exposure to the device's vapors appeared to increase the risk of clot formation.

Lowering hospitals' Medicare costs proves difficult

July 18, 2018
A payment system that provides financial incentives for hospitals that reduce health-care costs for Medicare patients did not lower costs as intended, according to a new study led by Washington University School of Medicine ...

People who tan in gyms tan more often, and more addictively, than others, new research shows

July 18, 2018
Gyms are places people go to get healthier. But nearly half the gyms in the U.S. contain a potentially addictive carcinogen—tanning beds, report UConn researchers in the July 18 issue of JAMA Dermatology.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.